Search results
This publication provides practical advice on issues in everyday practice, such as the procedure in the current coronavirus disease 2019 (COVID-19) pandemic, the cardiac risk under higher dosed H1 antihistamines, the self-administration of omalizumab as well as vaccination under omalizumab therapy.
7 mar 2013 · Methods. In this phase 3, multicenter, randomized, double-blind study, we evaluated the efficacy and safety of omalizumab in patients with moderate-to-severe chronic idiopathic urticaria who...
8 sie 2022 · The recommendations for the use of first-line treatment (antihistamine), second-line treatment (omalizumab), and third-line treatment (cyclosporine) now include guidance on updosing and duration (Fig 3, A and B).
31 sie 2022 · Chronic urticaria differs from acute urticaria in characteristics and treatments. The chronic form is spontaneous or inducible, with the latter elicited by cold, heat, pressure, or other...
1 cze 2017 · Most of the data on treatment of urticaria involve chronic cases. Current guidelines suggest a stepwise approach to treating chronic idiopathic urticaria 2, 9 (Figure 9 4).
Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the ...
13 lis 2021 · The recommendations relate to chronic spontaneous and inducible urticarias. Acute urticaria, angio-oedema without weals (other than idiopathic, which is now classified as part of CSU), hereditary angio-oedema and autoinflammatory diseases are not covered.
